Study revisits 1st clinical trial to treat MS decades later
Study revisits 1st clinical trial to treat MS decades later
Tracking down nearly all 372 multiple sclerosis patients involved in a pivotal clinical trial of a drug decades ago has allowed a group of researchers from several institutions, led by professors at the University of California, San Francisco (UCSF) and the University of Chicago, to a surprising discovery.
The clinical trial, conducted in the late 1980s, involved the biotech drug interferon beta-1b – an injectable protein that in 1993 became the first pharmaceutical approved by the U.S. Food and Drug Administration for treating multiple sclerosis.
Now, more than two decades later, the researchers are reporting that the people who received interferon in the trial, as opposed to a placebo, were only about half as likely to have died in the decades since....
Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1766
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 14508 Views
-
Last post by NHE
-
- 0 Replies
- 143 Views
-
Last post by DIM
-
- 1 Replies
- 2112 Views
-
Last post by raceya
-
- 0 Replies
- 1144 Views
-
Last post by frodo
-
- 0 Replies
- 1572 Views
-
Last post by DIM
-
- 0 Replies
- 2535 Views
-
Last post by DIM
-
- 0 Replies
- 2295 Views
-
Last post by DIM
-
- 0 Replies
- 1872 Views
-
Last post by frodo
-
- 0 Replies
- 2169 Views
-
Last post by Tif